Featured Stories

Imagio Combines Optoacoustics with Ultrasound for Breast Cancer Diagnosis

Coherent News-  January 8, 2018

New Data Supports Diagnostic Capability of Imagio™ Opto-Acoustic Breast Imaging System

MedLatest –  December 11, 2017

The Prognostic Potential of Opto-Acoustic Imaging in Patients with Breast Cancer

ConsultQD.clevelandclinic.org –  December 8, 2017

Opto-acoustic imaging (OA), an exciting new means of illuminating vascular properties of tumors and surrounding tissues, promises to be a clinical staple for evaluation and management of patients with breast cancer.


Seno Medical’s Imagio Combines Optoacoustics with Ultrasound to Diagnose Breast Cancer

medGadget –  December 5, 2017

Experimental Imaging Device Spots BrCA

MedPage Today –  November 30, 2017

Opto-acoustic ultrasound improves specificity compared with gray scale ultrasound


Optoacoustic Device Aids Breast Lesion Assessment

AuntMinnie.com –  November 29, 2017

Imagio™ Opto-Acoustic Breast Imaging System Reduces False Positive Breast Exams

MedLatest –  November 28, 2017

Seno Medical Presents Results of MAESTRO Study at EUSOBI

AuntMinnieEurope.com – September 27, 2016

Breast imaging developer Seno Medical Instruments announced interim results from its MAESTRO study at last week’s European Society of Breast Imaging (EUSOBI) meeting in Paris. The results from the study demonstrate the potential…


New Interim Results Support Imagio™ Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies

HealthCareBusiness Daily News (via PR Newswire) – Sepetmber 24, 2014

SAN ANTONIO, Sept. 24, 2016 /PRNewswire/ — Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer…


Seno Medical Reports Positive Interim Data from Maestro Study of Breast Imaging System

Medical Device Network Market & Customer Insight – September 26, 2016

US-based medical imaging company Seno Medical has reported positive interim results from its MAESTRO study of Imagio opto-acoustic (OA) a breast imaging system used to detect breast cancer…


New Interim Results Support Imagio Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies

BioSpace (via PR Newswire) – September 26, 2016

Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer, announced today…